(3R,5S)-5-((4-(1-(thiophen-3-ylsulfonyl)-1H-indol-5-ylamino)thieno[3,2-d]pyrimidin-6-yl)ethynyl)pyrrolidin-3-yl morpholine-4-carboxylate

ID: ALA452768

PubChem CID: 44564704

Max Phase: Preclinical

Molecular Formula: C29H26N6O5S3

Molecular Weight: 634.77

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5S(=O)(=O)c5ccsc5)c4)c3s2)C1)N1CCOCC1

Standard InChI:  InChI=1S/C29H26N6O5S3/c36-29(34-8-10-39-11-9-34)40-22-14-20(30-16-22)1-3-23-15-25-27(42-23)28(32-18-31-25)33-21-2-4-26-19(13-21)5-7-35(26)43(37,38)24-6-12-41-17-24/h2,4-7,12-13,15,17-18,20,22,30H,8-11,14,16H2,(H,31,32,33)/t20-,22-/m1/s1

Standard InChI Key:  HAYQBGMCBFKTMA-IFMALSPDSA-N

Molfile:  

     RDKit          2D

 43 49  0  0  0  0  0  0  0  0999 V2000
   -0.1713   -2.9046    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8858   -2.4921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8858   -1.6671    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1713   -1.2546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5431   -2.4921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5431   -1.6671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3278   -1.4121    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.8127   -2.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3278   -2.7470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1713   -0.4296    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6377   -2.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4627   -2.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2877   -2.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7726   -1.4121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5572   -1.6671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5572   -2.4921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7726   -2.7470    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2247   -1.1822    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9783   -1.5177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6458   -1.0328    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0646   -2.3382    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5595   -0.2123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2270    0.2726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9807   -0.0629    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0669   -0.8834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3995   -1.3683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8858   -0.0171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6003   -0.4296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6003    1.2204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8858    0.8079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3147    0.8079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3147   -0.0171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0994   -0.2720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5843    0.3954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0994    1.0629    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3543    1.8475    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5697    2.1024    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1389    1.5925    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6092    2.6321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3939    2.8870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3939    3.7120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6092    3.9670    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1243    3.2995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  6  1  0
 19 21  2  0
 20 22  1  0
  4 10  1  0
  5  6  2  0
  8 11  1  0
  1  2  2  0
 11 12  3  0
 20 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
  5  1  1  0
 10 27  1  0
 13 12  1  6
 27 28  2  0
 28 32  1  0
 13 14  1  0
 31 29  1  0
  2  3  1  0
 29 30  2  0
 30 27  1  0
 31 32  2  0
  3  4  2  0
  6  7  1  0
 14 15  1  0
 15 16  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 31  1  0
 16 17  1  0
 35 36  1  0
 17 13  1  0
 36 37  2  0
  7  8  1  0
 36 38  2  0
 39 40  1  0
 15 18  1  1
  8  9  2  0
 18 19  1  0
  9  5  1  0
 20 19  1  0
 40 41  2  0
 41 42  1  0
 42 43  1  0
 43 39  2  0
 36 39  1  0
M  END

Associated Targets(Human)

HN5 (111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-474 (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HFF (3142 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 634.77Molecular Weight (Monoisotopic): 634.1127AlogP: 4.24#Rotatable Bonds: 5
Polar Surface Area: 127.68Molecular Species: NEUTRALHBA: 12HBD: 2
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.25CX LogP: 3.97CX LogD: 3.07
Aromatic Rings: 5Heavy Atoms: 43QED Weighted: 0.27Np Likeness Score: -1.24

References

1. Waterson AG, Petrov KG, Hornberger KR, Hubbard RD, Sammond DM, Smith SC, Dickson HD, Caferro TR, Hinkle KW, Stevens KL, Dickerson SH, Rusnak DW, Spehar GM, Wood ER, Griffin RJ, Uehling DE..  (2009)  Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.,  19  (5): [PMID:19208477] [10.1016/j.bmcl.2009.01.080]

Source